Sumitomo Chemical India Limited has informed the Exchange regarding 'Financial Results for the Quarter ended 30th June, 2025 - machine readable.'.
SUMICHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.2 pts less than Nifty Smallcap 250 and 2.4 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sumitomo Chemical India reported its Q1 FY26 (quarter ended 30 June 2025) unaudited standalone and consolidated results, approved by the Board on 4 August 2025. Standalone revenue from operations rose to ₹10,480.69 million, up about 26% from ₹8,317.84 million in Q1 FY25, aided by strong demand during the Kharif season. Profit after tax climbed to ₹1,798.06 million, up roughly 40% year-on-year from ₹1,283.91 million, with EPS at ₹3.60 vs ₹2.57. Consolidated revenue and PAT showed a similar trajectory (₹10,567.79 million and ₹1,780.96 million respectively). B S R & Co. LLP issued an unmodified limited review report on both sets of results. The company operates in a single segment (agro-chemicals) and flagged that its business is seasonal and monsoon-dependent, and also noted the ongoing Delhi High Court hearing on the Glyphosate usage notification.
Strong double-digit growth in both revenue and profit, along with margin expansion, is a positive signal for shareholders and could support the stock in the near term, though the business remains exposed to monsoon variability and regulatory developments around Glyphosate.